Insmed
INSM
$24.80
Share price
-0.48%
Change (1 day)
28.83%
Change (1 year)
Categories
Insmed (INSM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.66 B
According to Insmed's latest financial reports the company's total liabilities are $1.66 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Insmed - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.66 B | 5.95% |
| 2022-12-31 | $1.56 B | 88.28% |
| 2021-12-31 | $0.83 B | 60.12% |
| 2020-12-31 | $0.52 B | 8.25% |
| 2019-12-31 | $0.48 B | 21.28% |
| 2018-12-31 | $0.39 B | 292.41% |
| 2017-12-31 | $0.10 B | 20.98% |
| 2016-12-31 | $83.47 M | 86.08% |
| 2015-12-31 | $44.85 M | 0.52% |
| 2014-12-31 | $44.62 M | 34.52% |
| 2013-12-31 | $33.17 M | 1.51% |
| 2012-12-31 | $32.67 M | 487.12% |
| 2011-12-31 | $5.56 M | 62.65% |
| 2010-12-31 | $3.42 M | 23.05% |
| 2009-12-31 | $2.78 M | -63.32% |
| 2008-12-31 | $7.58 M | -5.38% |
| 2007-12-31 | $8.01 M | -44.62% |
| 2006-12-31 | $14.46 M | 17.24% |
| 2005-12-31 | $12.34 M | 113.66% |
| 2004-12-31 | $5.77 M | 60.8% |
| 2003-12-31 | $3.59 M | -26.09% |
| 2002-12-31 | $4.86 M | -59.2% |
| 2001-12-31 | $11.91 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $54.57 B | 3,184.35% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $39.37 B | 2,269.54% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $5.14 B | 209.90% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $2.40 B | 44.74% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.53 B | -67.53% | 🇺🇸 USA |
 Array Technologies ARRY | $1.09 B | -34.03% | 🇺🇸 USA |